A few recent retrospective clinical studies correlated CSC phenotypes to radio-chemotherapy outcome in HNSCC including expression of CD44, CD24, integrin β1 and Oct4 [14, 18, 19]. Here, CD44 is linked to head and neck squamous cell carcinoma.